Showing posts sorted by relevance for query health. Sort by date Show all posts
Showing posts sorted by relevance for query health. Sort by date Show all posts

Saturday, 22 August 2020

Center for Health, Human Rights and Development (CEHURD) wins a victory against Uganda’s Neo-liberal State : Gov't fined Shs 310m over death of two pregnant women 10 years ago: We are too poor to fund health but too rich to spend on unclassified military expenditure: Judges can no longer deny Ugandans the right to health by hiding under the so called political doctrine


  Rhoda Kukiriza lost her daughter Sylvia Nalubowa while she was giving birth

Rhoda Kukiriza lost her daughter Sylvia Nalubowa While she was giving birth

Gov't fined Shs 310m over death of two pregnant women 10 years ago

 

 

Press Release: Landmark Hearing on Maternal Deaths Proceeds in Uganda’s Constitutional Court

 

(KAMPALA) Today a civil society coalition of more than 40 health rights organizations welcomed the start of Constitutional Court’s hearing of Petition 16 of 2011. This health rights case, filed on March 4, 2011 by the Centre for Health, Human Rights and Development (CEHURD), was triggered by the preventable deaths of Jennifer Anguko and Sylvia Nalubowa, two women who died while giving birth. The activists claim that Uganda’s government is failing to fulfill fundamental rights guaranteed under the Constitution, resulting in an epidemic of preventable deaths of women.

Constitutional Court dismissed the petition in 2012, on the grounds that the Court lacked standing to hear the case on its merits. CEHURD appealed to the Supreme Court (Constitutional Appeal No. 1 of 2013) and on September 30 2015 the Supreme Court ruled that Constitutional Court’s dismissal was incorrect, and must hear the petition.

More than 16 women die daily in Uganda from preventable causes including hemorrhage, sepsis, unsafe abortion, obstructed labor, and pre-eclampsia. There has been no statistically significant decrease in maternal mortality in Uganda for the last eight years (source: Uganda Demographic and Health Survey 2016 Key Indicators Report, page 58). Uganda’s severely high rates of teenage pregnancy also contribute to preventable maternal deaths—25% of young women 15-19 in Uganda is pregnant or a mother, one of the highest rates in sub-Saharan Africa, a statistic that has remained unchanged since 2006 (source: Uganda Demographic Health Survey, 2016).

The primary defense argued by Government over the last 8 years the case has been in Court is that Uganda is too poor to fight maternal mortality effectively. Recent evidence contradicts that claim: the FY2019/20Appropriations Bill contains a 20.9% expansion in the overall budget compared with FY2018/19. The increase is largely for Security (increasing from 6.3% to 9.3% of the budget) and Works and Transport (increasing from 14.6% to 16.2%). The Health budget share shrinks from 7.1% to 6.4%. By contrast, “Classified Expenditure and Assets” increased dramatically from UShs 934 billion in FY2018/19 to UShs 2.582 trillion in FY2019/20—the same size as the entire health budget.

Compounding the crisis caused by government under funding, are a series of recent policy shifts. In 2018 Government shut down free maternal health care services provided by Mulago National Referral Hospital, and instead opened a USD25 million super specialized private women’s clinic with no public wing. The private hospital charges exorbitant user fees most pregnant women cannot afford. Although government a decade ago pledged to provide emergency maternal health care services at local level by equipping Health Center IVs with the surgical theatres, health workers and commodities needed to save pregnant women’s lives, that promise has been broken, forcing pregnant women to rely on the national referral hospital.

The corrective actions being sought through this Constitutional Court Petition would help remedy these gross inequities, according to the advocates. “Deaths from maternal mortality could be largely eliminated in Uganda,” said Noor Musisi of CEHURD. “What we are missing is political will.”
Contact: Noor Nakibuuka Musisi, CEHURD 0782 496 681 or Asia Russell, Health GAP 0776 574 729


How the death of two Ugandan mothers is helping entrench the right to health care

Disclosure statement

Moses Mulumba receives funding from the Open Society Foundation and IDRC-Canada.
When Sylvia Nalubowa went into labour in Uganda’s Mityana district in August 2009, she was taken to a local health centre where she expected to have a normal birth, supervised by a midwife.
After she had delivered her first baby the midwife realised there was a twin on the way. The midwife recommended that Nalubowa be taken to the district hospital where a doctor could handle the second delivery.
But when she arrived at the Mityana District Hospital in Central Uganda, the nurses asked for her maternity kit. This is commonly known as a “mama kit” and contains a plastic sheet, razor blades, cotton wool or gauze pad, soap, gloves, cord ties, and a child health card. All mothers delivering babies in Ugandan hospitals and clinics are expected to bring their own “mama kits” when they go into labour.
But Nalubowa had used her “mama kit” at the first health facility when delivering her first child. The nurses would hear none of her excuses and demanded money to purchase the kit before they could attend to her.
Nalubowa and her baby died.
Jennifer Anguko died under similar circumstances. She arrived at the Arua hospital in North Western Uganda at 8.30am on December 10, 2010 but was not attended to for 12 hours by which time her condition and cries for help were out of control.
One hour later she was taken to theatre but she and her baby died during the procedure. The cause of her death listed in the post mortem report was a ruptured uterus.

The women’s cases are two of many

Sixteen women die in Uganda every day during child birth in instances that could be avoided. In 2011, the World Health Organisation reported that Uganda registers up to 440 deaths for every 100 000 live births.
This is unlike Rwanda where maternal mortality decreased by 77% between 2000 and 2013 and currently stands at 320 deaths for every 100 000 live births.
Most maternal deaths in Uganda are due to severe bleeding, infection, hypertensive disorders and obstructed labour. Others are due to causes such as malaria, diabetes, hepatitis and anaemia. All these are aggravated by pregnancy.
The Ugandan government is committed to providing all citizens with free health services. But it is common to go to a government health facility and find that medicines are not in stock and health workers are not paid. Patients also say that they are often met by health staff who are unenthusiastic about attending to patients expecting free services.
In 2013, the doctor to patient ratio in Uganda was estimated at one doctor for just under 25 000 patients. The nurse to patient ratio sat at one nurse for 11 000 patients.
The country’s public health system has a tiered structure with two national referral hospitals, 11 semi-autonomous regional referral hospitals, and a well established district health system with healthcare centres in 56 districts.
Health care services are financed through general tax revenue and donor funding. Although user fees for health services in public facilities were abolished in 2001 patients are still expected to make direct out-of-pocket payments for some services and drugs.

Fighting for a right

In 2011 lawyers at the Centre for health, Human Rights and Development, a non-profit, research and advocacy organisation, began gathering evidence to hold the Ugandan government to account for Nalubowa and Anguko’s deaths.
The case is now before the country’s Constitutional Court.
In what has turned into a landmark case, the centre has argued that failing to provide essential maternal health commodities in government health facilities is an infringement on women’s rights. The rights to life as well as health are guaranteed under the country’s constitution as well as international human rights instruments the government has signed up to. These include the:
  • International Covenant on Economic Social and Cultural Rights (ICESCR),
  • Convention of Elimination of All forms of Discrimination Against Women (CEDAW), and
  • Maputo protocol.

The court erred

At the first hearing before the Constitutional Court government lawyers objected to the case. They argued that the judiciary was not competent to hear a case that required the executive arm of government to allocate resources to the health sector.
The court agreed and dismissed the case.
But the centre appealed to the Supreme Court, the highest court of appeal in Uganda. It argued that the justices of the Constitutional Court erred in denying them an opportunity to hear the case based on its merits.
In October 2015 the Supreme Court’s seven judges agreed. They made a unanimous ruling that the Constitutional Court judges had erred in dismissing the case. In their judgment they argued that the case had key questions that needed constitutional interpretation for the people of Uganda.
They contended that there is nothing the executive or legislature can decide on that may not be subjected to judicial review - especially if it is done in line with the constitution. And they have ordered the Constitutional Court to hear the case which is now before the Constitutional Court pending a hearing by a new panel of judges.

Making health care a priority

The case has contributed to jurisprudence to help people realise their social economic rights in Uganda.
But it has also catalysed improvements in health service provision. Since the case was initially heard government funding for the health sector has improved from US$ 215 million (UGX 737.60 billion) to US$ 328 million (UGX 1127.48 billion) and more health workers have been recruited. Mothers, however, are still expected to bring their own “mama kits” when going into labour.
There has also been a reduction in maternal deaths. These have fallen from 440 deaths for every 100 000 live births in 2010 to 343 by 2015.
Most importantly, civil society organisations are now, more than ever, alert to demanding women’s health care rights.
*Primah Kwagala, a human rights lawyer at the Centre for Health, Human Rights and Development (CEHURD) where she manages strategic litigation programmes, was integral in the writing of this article.

Monday, 6 October 2014

There you go: Biological weapons' testing resumes in Uganda : Marburg kills one health worker, 80 under close watch - ministry:Marburg: Five more suspects reported, 97 being monitored


 Health ministry issues alert after Marburg death


FIRST READ: 

From Kibale( where Ebola started recently) to Kabale( where there is a Marburg virus outbreak): Marburg outbreak confirmed in Western Uganda: The test of biological weapons on African Guinea pigs is not over yet


 

I smell a rat but Jesus will always protect the poor Africans from Man’s wicked schemes !! Strange malaria-like disease hits Uganda: US experts to monitor deadly hemorrhagic fevers in Uganda: Oh: really: Why has Uganda become a home for all kinds of Hepatitis Out breaks ??


 


  Dear Global research.ca , The US invented the Ebola Virus from Bundibugyo, Uganda that is why they have a patent for their invention. The US’s invention of that virus is not a claim, it is the truth.


 


http://watchmanafrica.blogspot.com/2014/09/dear-global-researchca-us-invented.html


 


Wickedness in high places : When Ebola creators pretend to be messianic solvers on their own biological weapon : WHO meets on experimental Ebola drug use



http://watchmanafrica.blogspot.com/2014/08/wickedness-in-high-places-when-ebola.html

 


Marburg out break in Uganda : 132 now being monitored: Naïve Ugandans think the diseases has come about because Ugandans are dirty





From Marburg to Ebola, Destructing us from the exposed rot of Museveni’s US client state regime due to corruption : Ebola outbreak in Uganda is a mere political game speared headed by the US new world system to destruct us from the exposed Corruption in Museveni’s regime and the participation of Uganda in the support of M23 rebels





Ebola as a US neo-imperialistic weapon: Portray Africans as poor helpless zombies: Come in as a solution to the Ebola virus you have created : Use this pretext to steal their mineral resources : Obama: Ebola crisis 'spiraling out of control' : US military to help Ebola effort


http://watchmanafrica.blogspot.com/2014/09/ebola-as-us-neo-imperialistic-weapon.html 


 


 


 


THE DRUG EPIDEMIC, VIRUSES, EBOLA, AND AIDS[IT'S NOT WHAT YOU THINK

http://www.antipasministries.com/html/file0000081.htm


 


The Ebola Outbreak: U.S. Sponsored Bioterror? Why Was Ebola-Infected Patrick Sawyer Cleared for Travel?


http://watchmanafrica.blogspot.com/2014/08/the-ebola-outbreak-us-sponsored.html


 


Hypocrisy of Babylon USA: US waives child soldier sanctions on six nations


http://watchmanafrica.blogspot.com/2014/10/hypocrisy-of-babylon-usa-us-waives.html 


Marburg kills one health worker, 80 under close watch - ministry


Health officials bury a Marburg victim last year. FILE PHOTO 
By Agatha Ayebazibwe

Posted  Monday, October 6   2014 at  01:00
In Summary
The Ministry of Health has dispatched teams of epidemiologists to Mengo, Mpigi hospitals and Kasese District where the deceased was treated before his death 

Kampala.
The Ministry of Health and the World Health Organisation yesterday confirmed the outbreak of Marburg Viral fever in the country after one person died of the disease on September 28.
Laboratory test results done at Uganda Virus Research Institute confirmed that the 30-year old-man, a health worker at Mengo Hospital, died of Marburg.
The deceased man’s brother, who is also a health worker at the hospital, has also been quarantined at the facility after he presented with signs of the disease a few days after the first case was buried.
Samples have been taken to UVRI for further tests and the results are expected by midday.
According to the Acting Minister for Health, Dr Elioda Tumwesigye, the ministry has dispatched teams of epidemiologists to Mengo, Mpigi hospitals and Kasese District where the deceased was buried last month.
“We are tracing all the possible people that the deceased may have had contact with for close monitoring for at least 21 days. In the meantime, we call upon the public to remain alert and report any suspected cases,” Dr Elioda said.

According to a press statement issued by the ministry, the deceased, who originally worked at Mpigi Health Centre IV, had been recruited by Mengo Hospital two months ago as a radiographer.
“He started feeling unwell on September 17 while at Mengo Hospital and travelled back to Mpigi HCIV on September 18 to seek treatment since he felt more comfortable with a facility that he had worked with for a long time,” reads the statement.
He was treated at Mpigi Health Centre IV but when his condition worsened, he was transferred back to Mengo where he was admitted on September 23.
He presented with headache, bleeding from different body openings, abdominal pain, vomiting blood and diarrhoea.

He passed away on September 28 and his body was taken to Munkunyu village, Munkunyu Sub-county, Kasese for burial.
The minister said 80 people who got into contact with the initial confirmed case have been identified and isolated as a precautionary measure and for follow up for any signs and symptoms within the 21 days incubation period of the disease.

“They are currently being monitored by a team of epidemiologists from the Ministry of Health,” Dr Tumwesigye said while addressing the media yesterday in Kampala.
The WHO Country Representative, Dr Alemu Wondimagegnehu, said the public should not be frightened, necessary precautionary measures have been put in place to cantain the spread of the disease.
“There is no reason to panic. A team of experts has been put together to assess the situation where the deceased was treated,” Dr Wondimagegnehu said.
about marburg fever

Cause.
Marburg Viral Haemorraghic fever is a fatal illness caused by the Marburg virus which belongs to the same family together with the Ebola virus.
Incubation.
The incubation period ranges from two to 21 days while the case fatality rate varies from 24 to 88 per cent. The Marburg virus is transmitted to people from the fruit bats and spreads among humans through human-to-human transmission by direct contact with wounds and body fluids like blood, saliva, vomitus, stool and urine of an infected person.

Marburg: Five more suspects reported, 97 being monitored


An Ebola isolation unit at Mulago Hospital which is being rehabilitated to accommodate Marburg patients. PHOTO BY RACHEL MABALA 
By Agatha Ayebazibwe

Posted  Tuesday, October 7   2014 at  01:00
 
In Summary
On alert. Marburg samples picked Mpingi District to be examined by the virus institute. P.45 Marburg suspects reported 

Kampala. The Ministry of Health yesterday sent five more samples of the suspected Marburg fever to the Uganda Virus Research Institute (UVRI) for more tests after they presented signs of the disease.
On Sunday, the ministry confirmed a health worker had succumbed to the disease following laboratory tests done on September 30.

The ministry is also awaiting results of a sample from the deceased’s brother, who has so far been listed as having developed signs of the deadly disease. He has since been quarantined and isolated for further monitoring.

According to the World Health Organisation country representative, Dr Alemu Wondimagegnehu, the five samples were drawn from people who were in contact with the deceased while at Mpingi Health Centre IV.
“The information we got from the team on the ground is that the five presented with signs of the disease. The samples have been delivered at UVRI and results are expected soon,” Dr Wondimagegnehu told Daily Monitor in an interview.

A temporary isolation centre has been set up at Mpigi Health Centre IV where the suspected cases are being quarantined.

The permanent secretary in the Ministry of Health, Dr Asuman Lukwago, also said another 17 contacts have been identified in Kampala, bringing the total of those who were in contact with the deceased to 97.
“Our teams are still on the ground tracing all the possible contacts. Those who have been identified will be isolated in their homes for at least 21 days. If they show any signs such as fever and headache, then we take their samples for further tests,” Dr Lukwago told Daily Monitor.

He added that results of the six samples are expected in a few hours.
However, some officials have expressed concern over the ministry’s preparedness to handle the crisis, should it become a fully-fledged Marburg outbreak.

“The confirmatory test results were received at the Ministry of Health on September 30, but to date, the ministry has not released any money to facilitate the teams to respond appropriately,” said a source within the ministry who preferred to remain anonymous.

But Dr Lukwago said they are still treating the matter as an emergency, saying those involved can use their money which will be refunded once the ministry gets the money.

“We are aiding them with things such as fuel, cars to enable them move from one place to another. We also expect to have a costed plan for the response in the next 36 hours,” he added.
About the disease
Cause. Marburg Viral Haemorraghic fever is caused by the Marburg virus which belongs to the same family together with the Ebola virus. The incubation period ranges from two to 21 days while the case fatality rates vary from 24 per cent to 88 per cent..

Spread. Fruit bats of the Pteropodidae family are considered to be the hosts of Marburg. The virus spreads among humans through human-to-human transmission by direct contact with wounds and body fluids.
Symptoms. Headache, vomiting blood, joint and muscle pains, bleeding through the body openings, such eyes, nose, gums, ears, anus and the skin.

US experts to monitor deadly hemorrhagic fevers in Uganda


http://www.newvision.co.ug/news/652020-us-experts-to-monitor-deadly-hemorrhagic-fevers-in-uganda.html  By John Agaba

The United States Department of Defense is partnering with the health ministry to improve regional surveillance of deadly hemorrhagic fevers such as Marburg and Ebola.
 

This was revealed Thursday by the health ministry’s Permanent Secretary, Dr. Asuman Lukwago, during the occasion to hand over 19 vehicles to facilitate monitoring and evaluation of health activities in the country.


Lukwago said a team of experts from the US Defense Department had already touched base in the country and was setting up structures on effective monitoring and control of the deadly fevers.


He said they are going to put epidemiologists (health experts) in every region of the country to constantly be on the lookout for any outbreak.



“In case any disease breaks up, these epidemiologists will be able to detect it very fast,” said Lukwago.


He said they were also working with the Uganda Virus Research Institute (UVRI) in Entebbe and the US Centres for Disease Control and Prevention (CDC) so for any disease outbreak, samples can be taken at the Institute and diagnosis done quickly.


A statement from the CDC, also released yesterday, read that preventing, detecting and responding to outbreaks as early and effectively as possible was necessary to keep the world safe and secure from infectious disease threats.


The statement indicated that the CDC has been partnering with the health ministry to effectively monitor and control the deadly pathogens for the last six months. And that the partnership had resulted in improvements in disease detection and response.


Uganda has had its share of the deadly pathogens, the prominent cases being of Ebola and the Marburg virus which killed scores of people in Kabale district in 2012.


Health ministry issues alert after Marburg death

Publish Date: Oct 05, 2014
Health ministry issues alert after Marburg death
State Minister for Health, Elioda Tumwesigye (left) and Director General of health services, Jane Ruth Aceng addressing the press in Kampala. PHOTO BY LAWRENCE KITATTA
By Vision Reporter
The Ministry of Health has today announced one fatal case of Marburg disease. The victim is a 30 year old health worker.

The victim had been a radiographer, or X-ray technician, at the Mpigi Health Centre IV, but was recruited two months ago for a similar position at Mengo Hospital. When he felt ill on September 17, he traveled back to Mpigi for treatment since “he felt more confortable with a facility that he had worked with for a long time.”
Marburg is one of the five members of the family of filoviruses, to which Ebola belongs. Like Ebola, a person infected with Marburg will experience a sudden onset of fever.

The most common additional signs are headache, joint and muscle pains, vomiting blood, and bleeding through body openings. The disease has a two to 21-day incubation period and, like Ebola, has no cure other than supportive treatment.

Today’s statement from Elioda Tumwesigye, Minister of State for General Duties & Holding the Portfolio of Minister for Health, describes a total of 80 people who were in contact with the man have been identified and isolated to follow for signs and symptoms.
President Yoweri Museveni immediately called for vigilance. "The Ministry of health is tracing all the people including relatives who may have been in close contact. Please report suspicious cases," Museveni said on twitter.
"Stay calm but vigilant. Avoid shaking hands and cooperate with health workers."
Prime Minister Ruhakana Rugunda reassured the country of measures to control the disease.
"Marburg is a Viral Hemorrhagic fever caused by the Marburg virus. Ministry of Helath has put in place rigorous surveillance and disease control measures.  Uganda has experience and adequate capacity to deal with this health threat & World Health Organisation has been informed," Prime Minister Ruhakana Rugunda said.

"The public has also been alerted to report any suspected cases on the Ministry hotline on +256750996034, " he added.

"Uganda has previously successfully handled similar situations of health threats involving Hemorrhagic fevers."
FULL STATEMENT
Ministry of Health Press Statement on confirmed Marburg Fever death
The Ministry of Health would like to inform the general public that there is a confirmed case of Marburg in the country. 
This initial case follows laboratory tests done at the Uganda Virus Research Institute (UVRI) on September 30th 2014 which confirmed that one person, a health worker, had died of the viral hemorrhagic fever.

The index case is a 30-year-old male Radiographer, who originally was working in Mpigi Health Centre IV, Mpigi Town Council but had been recruited by Mengo Hospital two month ago as a Radiographer. He started feeling unwell on September 17th while at Mengo Hospital and travelled back to Mpigi HCIV on September 18th to seek treatment since he felt more comfortable with a facility that he had worked with for a long time. 
He was treated at Mpigi Health Center IV but when his condition worsened, he was transferred back to Mengo Hospital where he was admitted on September 23rd. He presented with Headache, Epistaxis, abdominal pain, vomiting blood and diarrhea. His condition deteriorated on September 27th and a Viral Haemorraghic fever was suspected. Blood samples were removed for further analysis on September 28th; unfortunately he died on the same day. His body was taken to Munkunyu 1 Village, Munkunyu Sub-county, Kasese district for burial.

Preliminary reports also show that his brother, one of the contacts so far listed has developed signs. He has been quarantined and isolated for further monitoring. Samples have been taken from him and are being tested at the Uganda Virus Research Institute. The public will be informed of his status. Altogether 80 contacts have been listed from Mengo, Mpigi and Kasese for follow up. 

Marburg Viral Haemorraghic fever is a fatal illness caused by the Marburg virus which belongs to the filoviridae family together with the Ebola virus. The incubation period ranges from 2 to 21 days while the Case fatality rates vary from 24% to 88%. Fruit bats of the Pteropodidae family are considered to be the natural hosts of Marburg virus. The Marburg virus is transmitted to people from the fruit bats and spreads among humans through human-to-human transmission by direct contact with wounds and body fluids like blood, saliva, vomitus, stool and urine of an infected person.
A person suffering from Marburg presents with sudden onset of high fever with any of the following; 
1. Headache
2. Vomiting blood
3. Joint and muscle pains
4. Bleeding through the body openings, i.e. eyes, nose, gums, ears, anus and the skin. 
There is no specific antiviral treatment or vaccine available; patients are usually given supportive treatment.
The Ministry of Health is undertaking the following measures to control the spread of the disease;
• Yesterday, a team of epidemiologists and surveillance officers were sent to Mpigi Health Center IV, Mengo Hospital and to Kasese district to investigate the case and list all people who got into contact with the dead. 
• So far, a total of 80 people who got into contact with the initial confirmed case have been identified and isolated as a precautionary measure and for follow up for any signs and symptoms within the 21 days incubation period. These include 38 health workers from Mengo Hospital, including his brother and 22 health workers from Mpigi Health Center IV and 20 people from Kasese district. They are currently being monitored by a team of epidemiologists from the Ministry of Health. 
• Arrangements have been put in place to transport all suspect cases to the National Isolation Facility in Entebbe should they occur. The facility is already stocked with the necessary infection control materials and other supplies to handle any incoming patients. 
• Arrangements have also been made at Mengo Hospital to isolate any suspect with symptoms. Health workers have been asked to effect all infection control measures. 
• Preparations are underway to train all health workers at Mengo Hospital and Mpigi Health Center IV on infection control starting tomorrow 6/10/2014 at 9.00am
• Government working with partners and specifically Medicens San Frontiers (MSF) are in the process of revamping the isolation facility at Mulago National Referral Hospital under the leadership of Kampala Capital City Authority in readiness and the facility will be ready in three days time. 
• MSF is also mobilizing additional resources to assist with infection control and case management at all the isolation facilities that have been set up.
• The World Health Organization (WHO) is providing technical assistance and logistical support (PPE’s) to all the affected facilities.
• In Kasese, a team has been dispatched to work with the district official and Kagando Hospital to trace for any other suspects. 
• Personal Protective Equipments (PPE’s) and other supplies have been mobilized and sent to Mengo and Mpigi health center IV and Kagando HCIV.
• National Medical Stores will supply additional infection control materials to Mengo Hospital and Mpigi HCIV by tomorrow morning. 
The Ministry of Health however informs the general Public that Mengo Hospital is safe and all measures have been taken to ensure that there is no further spread of infection. Patients are encouraged to continue to receive services from there. 
Ministry of Health urges the general public to observe the following protective measures;
• Report any suspected patient to a nearby health unit 
• Avoid direct contact with body fluids of a person presenting with bleeding tendencies or symptoms of Marburg. 
The Ministry of Health once again calls upon the public to remain calm and be on alert amidst this epidemic. All suspect cases can be reported on the Ministry hotline on +256750996034. 

Hon. Elioda Tumwesigye
Minister of State for General Duties &
Holding the Portfolio of Minister for Health

Monday, 25 May 2026

The Money Politics of Ebola Infections: Uganda confirms 3 new Ebola cases

 

Dr Diana Atwine, ministry of Health PS

  FIRST READ:


Testing biological weapons on Ugandan Guinea pigs: Deadly Ebola virus breaks out in Luweero(Uganda)

 
 

CHRISTIANS IN AFRICA: AWAKE!
America and the American Church Are Not Your Friends

http://takeheedafrica.blogspot.com/2008/03/christians-in-africa-awake.html 


Hillary Clinton’s messianic entry into Uganda amidst the politics of Ebola scare: US’ Hillary starts Africa tour, here in Uganda tomorrow: Washington says Ms Clinton’s meeting with Museveni on Friday will focus on regional security, human rights and democracy: Oh! Really



THE DRUG EPIDEMIC, VIRUSES, EBOLA, AND AIDS[IT'S NOT WHAT YOU THINK

http://www.antipasministries.com/html/file0000081.htm

 

The evil that humans do: Ebola Kills 14 in Kibale District of Uganda: Locals believed the illnesses were the result of an attack of evil spirits, send the sick for prayers

http://watchmanafrica.blogspot.com/2012/07/the-evil-that-human-do-ebola-kills-14.html

Inside man ‘s dark and wicked heart: More tests of biological weapons on African Guinea pigs: At least 59 people dead in Guinea Ebola outbreak

From Uganda now to DR Congo test of Ebola on African Guinea Pigs Continues: 31 people including 5 health-care workers die from Ebola virus in Congo

Uganda confirms 3 new Ebola cases

https://observer.ug/news/uganda-confirms-3-new-ebola-cases/ 

The ministry of Health has confirmed three new cases of Ebola Virus Disease, bringing the total number of confirmed infections recorded in Uganda to five.

The new cases include a Ugandan driver who transported the country’s first confirmed patient and later succumbed to complications linked to the disease, as well as a health worker who had been involved in managing the patient.

According to Dr Charles Olaro, the director general of health services, the third new case involves a Congolese woman who entered Uganda through the Arua border before travelling to Entebbe.

A statement from the ministry of Health indicates that the woman used a chartered flight from Arua to Entebbe and later sought treatment at a private hospital in Kampala.

The hospital reportedly discharged the woman, who subsequently travelled back to the Democratic Republic of Congo (DRC). However, samples taken by Ugandan authorities later returned positive for Ebola after she had already left the country.

 The latest infections come as Ugandan authorities continue to contest the World Health Organization’s decision to classify Uganda together with the DRC in the current outbreak response, despite Uganda having recorded only a handful of confirmed cases compared to the dozens of infections and deaths reported across the border.

 

Addressing a press conference on Thursday, Dr Diana Atwine, permanent secretary at the ministry of Health, announced restrictions on travel to the DRC, arguing that Uganda had not registered active positive cases at the time because the only imported patient receiving treatment in the country had tested negative.

Meanwhile, the United States earlier this week updated its travel advisory, warning Americans against travelling to the DRC, South Sudan and Uganda, while advising travellers to reconsider trips to Rwanda because of the Ebola Bundibugyo Virus Disease outbreak in the region.

“The Department’s Travel Advisories for DRC, South Sudan, and Uganda are now Level 4 – Do Not Travel, and the Travel Advisory for Rwanda is Level 3 – Reconsider Travel,” the notice on the U.S. Embassy website stated.

 

One American who had travelled to the DRC tested positive for Ebola and was later evacuated to Germany for treatment.

The current outbreak involving the Bundibugyo strain marks the second such outbreak to be recorded in both Uganda and the DRC. Both countries have previously experienced multiple Ebola outbreaks linked to the Zaire strain.

Health experts warn that the Bundibugyo strain remains a significant public health threat, particularly because there are currently no approved vaccines or specific therapeutics targeting it. Treatment efforts largely rely on supportive care, while the fatality rate for the disease is estimated at about 40 per cent.

 

Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda 

https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON602  

16 May 2026

Situation at a glance

On 5 May 2026, the World Health Organization (WHO) was alerted of a high-mortality outbreak of unknown illness in Mongbwalu Health Zone, Ituri Province, Democratic Republic of the Congo (DRC), including deaths among health workers. On 14 May 2026, the Institut national de recherche biomédicale (INRB) Kinshasa analyzed 13 blood samples from Rwampara Health Zone, Ituri Province. Laboratory analysis confirmed Bundibugyo virus disease (BVD) in eight of these samples on 15 May, a species of Ebola. The case fatality rates in the past two BVD outbreaks have ranged from 30% to 50%. Unlike Ebola virus disease, there is no licensed vaccine or specific therapeutics against Bundibugyo virus, though early supportive care is lifesaving. On 15 May 2026, the Ministry of Public Health, Hygiene and Social Welfare, DRC, officially declared the 17th Ebola Disease outbreak in DRC. Concurrently, the Uganda Ministry of Health confirmed an outbreak of BVD following the identification of one imported case from DRC, a Congolese man who died in the capital city of Kampala. On 16 May 2026, WHO Director-General, after having consulted the States Parties where the event is known to be currently occurring, determined that the Ebola disease caused by Bundibugyo virus in DRC and Uganda constitutes a public health emergency of international concern (PHEIC), as defined in the provisions of IHR. Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centers, and community engagement. WHO is supporting the coordination of the response, case management, and cross-border preparedness. WHO advice has been issued to countries.

Description of the situation

On 5 May 2026, WHO received an alert regarding an unknown illness with high mortality reported in Mongbwalu Health Zone, Ituri Province, including four health workers who died within four days. Following an in-depth investigation by the rapid response team in Mongbwalu and Rwampara health zones (HZ) on 13 May, the outbreak was subsequently confirmed as Bundibugyo virus disease (BVD) due to Bundibugyo virus (BDBV) (Orthoebolavirus bundibugyoense, species) on 15 May.

On 15 May 2026, the Ministry of Public Health, Hygiene and Social Welfare officially declared the 17th Ebola Disease outbreak in the DRC, occurring in Rwampara, Mongwalu and Bunia HZ.

The first currently known suspected case, a health worker, reported onset of symptoms including fever, hemorrhaging, vomiting and intense malaise on 24 April 2026. The case died at a medical centre in Bunia.

As of 15 May, a total of 246 suspected cases and 80 deaths (four deaths among confirmed cases) have been reported from three HZ: Rwampara (six health areas affected), Mongbwalu (three health areas affected), and Bunia .  Twenty four suspected cases are currently in isolation facilities across the three HZ.  In addition, unusual clusters of community deaths with symptoms compatible with Bundibugyo virus disease (BVD) are being investigated across other HZ in Ituri and North Kivu.

A further case reported on 16 May, an individual returning from Ituri to Kinshasa, has tested NEGATIVE for Bundibugyo virus on confirmatory testing by the Institut National de la Recherche Biomédicale (INRB) of DRC, and is therefore not considered a confirmed case.

Most of the suspected cases are between 20 and 39 years old, with females accounting for over 60%, suggesting significant risks associated with household and caregiver transmission.

Initial testing of 20 samples collected in Rwampara HZ and analysed at the Provincial Public Health Laboratory in Bunia using standard Ebola Xpert were negative for Ebola virus. Samples were sent to INRB for further analysis, of which eight samples analysed were confirmed as Orthoebolavirus by polymerase chain reaction (PCR) on 15 May. Genomic sequencing confirmed the virus species as Bundibugyo virus (BDBV).

As of 15 May, 65 contacts have been listed, with 15 identified as high-risk. However, follow-up remains weak due to insecurity and movement restrictions. Several listed contacts became symptomatic and died before they could be isolated.

On 15 May 2026, the Ministry of Health of Uganda confirmed an outbreak of BVD following the identification of an imported case from the DRC. The case is an elderly man who was admitted to a private hospital on 11 May with severe symptoms and died on 14 May. The post-mortem transfer of the body to DRC was completed the same day. A clinical sample collected when the case was admitted on 11 May was tested at the Central Emergency Surveillance and Response Support Laboratory, Wandegeya, and was confirmed as Bundibugyo virus on 15 May 2026. A second imported case was confirmed on 16 May in Kampala, in an individual returning from DRC with no apparent links to the first case. At the time of reporting, no local transmission has been identified in Uganda.

On 16 May 2026, the Director-General of WHO, after having consulted the States Parties where the event is known to be currently occurring as defined in the provisions of the International Health Regulations (2005) (IHR), determined that the Ebola disease caused by Bundibugyo virus in DRC and Uganda constitutes a PHEIC.

It is currently thought that the event originated in the Mongbwalu HZ, DRC, a high-traffic mining area, with cases subsequently migrating to Rwampara and Bunia to seek medical care. Ituri province borders South Sudan and Uganda (and Bunia HZ is less than 500km from Uganda). A full epidemiological investigation and trace back exercise is ongoing.

Ituri’s role as a commercial and migratory hub and proximity to Uganda and South Sudan increases the risk of regional exportation and cross-border transmission.

Figure 1. Health Zones affected by Bundibugyo virus disease in Democratic Republic of Congo, as of 16 May 2026

Map_Ebola disease caused by Bundibugyo virus DRC

Epidemiology

Bundibugyo virus disease (BVD) is a severe and often fatal form of Ebola disease caused by the Bundibugyo virus, one of the Orthoebolavirus species. It is a zoonotic disease, with fruit bats suspected to be the natural reservoir. Human infection occurs through close contact with the blood or secretions of infected wildlife, such as bats or non-human primates, and subsequently spreads from person to person through direct contact with the blood, secretions, organs, or other bodily fluids of infected individuals or contaminated surfaces. Transmission is particularly amplified in health-care settings when infection prevention and control (IPC) measures are inadequate, and during unsafe burial practices involving direct contact with the deceased.

The incubation period for BVD ranges from 2 to 21 days, and individuals are usually not infectious until symptom onset. Early symptoms are non-specific, including fever, fatigue, muscle pain, headache, and sore throat, which complicates clinical diagnosis and can delay detection. These progress to gastrointestinal symptoms, organ dysfunction, and in some cases haemorrhagic manifestations. Case fatality rates in the past two BVD outbreaks, reported in Uganda and in DRC in 2007 and 2012, have ranged from approximately 30% to 50%.

Differentiating BVD from other endemic febrile illnesses such as malaria is challenging without laboratory confirmation using PCR or antigen/antibody-based assays. Control relies on rapid case identification, isolation and care, contact tracing, safe burials, and strong community engagement, as no approved vaccines or specific treatments currently exist for BVD.

Public health response

Health authorities in DRC are implementing public health measures, including but not limited to the following:

Coordination

  • Rapid response teams have been deployed to Rwampara and Mongbwalu HZ.
  • Provincial coordination and emergency meetings by le centre d’operation des urgences en sante publique (COUSP) have been held.

Surveillance and Laboratory

  • Surveillance for suspected and probable cases is ongoing (including at relevant Points of Entry and borders).
  • Operational case definitions have been elaborated in Ituri.
  • Sequencing confirmed Bundibugyo virus in positive RT-PCR samples.

Risk Communication and Community Engagement (RCCE)

  • Social mobilization meeting was held with community leaders in the Rural commune of Mongbwalu under the leadership of the Mayor.

Infection Prevention and Control (IPC)

  • IPC assessment in key health facilities is ongoing: Bunia Hospital Centre of the Evangelical Medical Centre (CME), Mongbwalu General Referral Hospital and Abelkozo Health Centre.
  • CME Bunia is maintaining isolation protocols. Healthcare workers have been briefed on the specific diagnostic profile of this strain.

Logistics

  • Logistical support has been provided for investigations in Mongbwalu and Rwampara Health Zones.
  • Support has been provided for the transportation of samples to INRB Kinshasa.

Health authorities in Uganda are implementing public health measures, including but not limited to the following:

  • Activating national and district-level emergency measures, including enhanced surveillance, screening at borders, deployment of rapid response teams, isolation of a high-risk contact, and quarantine of all identified contacts.
  • Strengthening of preparedness activities such as mobile laboratory deployment, infection prevention, and risk communication.
  • Rapid response readiness teams have been deployed at all official and informal points of entry along the western border, major transit routes, and pilgrimage corridors.
  • Advising health workers to remain vigilant and adhere strictly to infection prevention measures.

WHO is supporting the national authorities, including through:

  • Deployment of technical expertise and rapid response teams to support response efforts.
  • Deployment of IPC, clinical management and sample collection kits.
  • Identification of isolation facilities for case management in Bunia, Rwampara, and Mongbwalu HZ .
  • Dissemination of WHO case management protocol.
  • In-depth investigations and listing of contacts of suspected/probable cases.
  • Strengthening epidemiological surveillance, IPC and RCCE at all points of entry.
  • Strengthening Point of Entry (PoE) screening and cross border coordination, including mass gatherings.
  • Supporting the Ministry of Health in implementation of the Response Plan and WHO internal Response Plan.
  • Following up with the IHR National Focal Points (IHR NFP) in DRC and Uganda on the official IHR notification while concurrently managing communication across the IHR NFP network to ensure timely coordination.
  • Coordinating the delivery of key supplies.
  • Engaging experts on research and development priorities. 

WHO risk assessment

On 16 May 2026, WHO Director-General, after having consulted the States Parties where the event is known to be currently occurring, determined that the Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda constitutes a public health emergency of international concern (PHEIC), as per the provisions of the IHR. Temporary recommendations for State Parties will be issued.  In the meantime, WHO issued advice to countries, as stated below.

This is the 17th Ebola disease outbreak in the DRC since 1976. The last Ebola disease outbreak in the country was declared on 4 September 2025 with total of 64 cases (53 confirmed, 11 probable), including 45 deaths (CFR 70.3%), reported from six health areas in Bulape Health Zone, Kasai Province. The end of outbreak was declared on 1 December 2025. The last BVD outbreak was reported on 17 August 2012 by the DRC Ministry of Health in Province Orientale.  A total of 59 cases, 38 confirmed and 21 probable cases, including 34 deaths were reported. The outbreak was declared over on 26 November 2012 by the MOH.

This outbreak is occurring in a complex epidemiological and humanitarian context. A critical four-week detection gap between the onset of symptoms of the presumed index case (25 April 2026) and the laboratory confirmation of the outbreak (14 May 2025) suggests a low clinical index of suspicion among healthcare providers. This is compounded by the presence of co-circulating arboviruses and influenza-like illnesses, masking the initial index of suspicion for Ebola disease and exacerbating community transmission. Furthermore, the infection and death of four healthcare workers within a four-day span at Mongbwalu General Referral Hospital underscores critical breaches in IPC protocols. A large number of community deaths has been reported potentially associated with unsafe burial practices.

Ongoing conflict in Ituri province restricts the movement of surveillance teams, limits the deployment of Rapid Response Teams, and hinders the secure transport of laboratory samples. Contact tracing is challenging due to difficult access and highly mobile populations, increasing the risk of high-risk contacts being lost to follow up or never identified.

Ituri’s role as a commercial and migratory hub increases the risk of regional exportation. The proximity to Uganda and South Sudan increases the risk of cross-border transmission if PoE screening and cross border coordination and information sharing are not immediately reinforced. On 15 May 2026, the Ministry of Health of Uganda reported an imported case of BVD.

Humanitarian needs in the area are dire. Ituri has 273 403 displaced people, with a total of 1.9 million people in need according to the Humanitarian Response Plan 2026 for DRC. From January to March 2026, 32 600 newly displaced and 30 200 returnees were recorded. The province recorded 5800 protection incidents and 11 incidents against humanitarian actors.

Unlike Ebola virus disease, there is no licensed vaccine or specific therapeutics against BDBV. Research and development activities are activated to coordinate efforts to advance potential candidate medical countermeasures. Response and outbreak control relies entirely on a range of interventions and public health measures that will need to be thoroughly implemented, including supportive care, early detection, adequate IPC, rigorous contact tracing, safe burials, and community engagement.

WHO advice

For countries where the event is occurring (the Democratic Republic of the Congo and Uganda)

Coordination and high-level engagement 

  • Activate their national disaster/emergency management mechanisms and establish an emergency operation centre, under the authority of the Head of State and relevant government authority, to coordinate response activities across partners and sectors to ensure efficient and effective implementation and monitoring of comprehensive Bundibugyo virus disease control measures. These measures must include enhanced surveillance including contact tracing, infection prevention and control (IPC), risk communication and community engagement, laboratory diagnostic testing, and case management. Coordination and response mechanisms should be established at national level, as well as at subnational level in affected areas and at-risk areas.
  • Should national capacities be overwhelmed, collaboration with partners should be enhanced to strengthen operations and ensure the ability to implement control measures in all affected and neighbouring areas. 

Risk communication and community engagement 

  • Ensure that there is a large-scale and sustained effort to fully engage the community – through local, religious and traditional leaders and healers – so communities play a central role in case identification, contact tracing and risk education; the population should be made fully aware of the benefits of early treatment.
  • Strengthen community awareness, engagement, and participation in particular to identify and address cultural norms and beliefs that serve as barriers to their full participation in the response, and integrate the response within the wider response required to address the needs of the population, particularly in contexts of the protracted humanitarian crisis in Eastern DRC.

Surveillance and laboratory  

  • Strengthening surveillance and laboratory capacity across affected provinces and neighbouring provinces, through the establishment of (1) dedicated surveillance and response cells within affected health zones and across key at-risk neighbouring health zones; (2) enhanced community surveillance, particularly focused on community deaths; and (3) decentralized laboratory capacity for testing of Bundibugyo virus. 

Infection prevention and control in health facilities and in the context of care

  • Strengthen measures to prevent nosocomial infections, including systematic mapping of health facilities, triage, targeted IPC interventions and sustained monitoring and sustained supervision.
  • Ensure healthcare workers receive adequate training on IPC, including the proper use of PPE, and that health facilities have appropriate equipment to ensure the safety and protection of their staff, their timely payment of salaries and, as appropriate, hazard pay.

Patients’ referral pathway and access to safe and optimized intensive care. 

  • Ensure that suspected cases can be safely transferred to specialized clinical units for their isolation and management in a human and patient-centred approach.
  • Establish specialized treatment centers or units, located close to outbreak epicenter(s), with staff trained and equipped to implement optimized intensive supportive care. 

Research and development of medical countermeasures

  • Implement clinical trials to advance the development and use of candidate therapeutics and vaccine, supported by partners. 

Border health, travels and mass-gathering events 

  • Undertake cross-border screening and screening at main internal roads to ensure that no suspected case is missed and enhance the quality of screening through improved sharing of information with surveillance teams.
  • There should be no international travel of Bundibugyo virus disease contacts or cases, unless the travel is part of an appropriate medical evacuation. To minimize the risk of international spread of Bundibugyo virus disease:
  • Confirmed cases should immediately be isolated and treated in a Bundibugyo virus disease Treatment Centre with no national or international travel until two Bundibugyo virus-specific diagnostic tests conducted at least 48 hours apart are negative;
  • Contacts (which do not include properly protected health workers and laboratory staff who have had no unprotected exposure) should be monitored daily, with restricted national travel and no international travel until 21 days after exposure;
  • Probable and suspect cases should immediately be isolated and their travel should be restricted in accordance with their classification as either a confirmed case or contact.
  • Implement exit screening of all persons at international airports, seaports and major land crossings, for unexplained febrile illness consistent with potential Bundibugyo virus disease. The exit screening should consist of, at a minimum, a questionnaire, a temperature measurement and, if there is a fever, an assessment of the risk that the fever is caused by Bundibugyo virus disease. Any person with an illness consistent with Bundibugyo virus disease should not be allowed to travel unless the travel is part of an appropriate medical evacuation.
  • Consider postponing mass gatherings until BVD transmission is interrupted.

Safe and dignified burials 

  • Ensure funerals and burials are conducted by well-trained personnel, with provision made for the presence of the family and cultural practices, and in accordance with national health regulations, to reduce the risk of Bundibugyo virus infection. The cross-border movement of the human remains of deceased suspect, probable or confirmed Bundibugyo virus disease cases should be prohibited unless authorized in accordance with recognized international biosafety provisions.

Operations, supplies and logistics

  • Strong supply pipeline needs to be established to ensure that sufficient medical and laboratory commodities and other critical items, especially personal protective equipment (PPE), are available to those who appropriately need them. WHO advises against any restrictions on travel and/or trade to DRC or Uganda based on available information for the current outbreak.

For countries with land borders adjoining countries with documented Bundibugyo virus disease 

  • Unaffected States Parties with land borders adjoining States Parties with documented Bundibugyo virus disease  transmission should urgently enhance their preparedness and readiness capacity, including active surveillance across health facilities with active zero reporting, enhancement of community surveillance for clusters of unexplained deaths; establish access to a qualified diagnostic laboratory; ensure that health workers are aware of and trained in appropriate IPC procedures; and establish rapid response teams with the capacity to investigate and manage BVD cases and their contacts.
  • Dedicated coordination mechanisms should be in place at national and subnational level in all Unaffected States Parties with land borders adjoining States Parties with documented cases of Bundibugyo virus disease. States should be prepared to detect, investigate, and manage Bundibugyo virus disease cases; this should include assured access to a qualified diagnostic laboratory for Bundibugyo virus disease, isolation and case management capacity and activation of rapid response teams. 
  • Any State Parties newly detecting a suspected or confirmed Bundibugyo virus disease case or contact, or clusters of unexplained deaths should treat this as a health emergency, take immediate steps in the first 24 hours to investigate and stop a potential outbreak by instituting case isolation, case management, establishing a definitive diagnosis, and undertaking contact tracing and monitoring as required.
  • If Bundibugyo virus disease is confirmed to be occurring in the State Party, the full recommendations for State Parties with Bundibugyo virus disease transmission should be implemented, on either a national or subnational level, depending on the epidemiologic and risk context. State Parties should immediately report the confirmation of Bundibugyo virus disease to WHO.
  • Risk communications and community engagement, especially at points of entry, should be increased.
  • At-risk countries should put in place approvals for investigational therapeutics as an immediate priority for preparedness.

For all other countries

  • No country should close its borders or place any restrictions on travel and trade. Such measures are usually implemented out of fear and have no basis in science. They push the movement of people and goods to informal border crossings that are not monitored, thus increasing the chances of the spread of disease. Most critically, these restrictions can also compromise local economies and negatively affect response operations from a security and logistics perspective.
  • National authorities should work with airlines and other transport and tourism industries to ensure that they do not exceed WHO’s advice on international traffic.
  • States Parties should provide travelers to Bundibugyo virus disease affected and at-risk areas with relevant information on risks, measures to minimize those risks, and advice for managing a potential exposure.
  • The general public should be provided with accurate and relevant information on the Bundibugyo virus disease outbreak and measures to reduce the risk of exposure.
  • State Parties should be prepared to facilitate the evacuation and repatriation of nationals (e.g. health workers) who have been exposed to Bundibugyo virus disease.
  • Entry screening at airports or other ports of entry outside the affected region are not considered needed for passengers returning from areas at risk.

Further information

Citable reference: World Health Organization (17 May 2026). Disease Outbreak News; Bundibugyo Virus Disease, Democratic Republic of the Congo (The) and Uganda. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON602